Anne Breen is an meningioma survivor since 1986 in my own FDA investigational clinical trial of mifepristone (RU-486) for meningioma control since Feb 2005. Meningiomas are now 34% of new primary brain tumors, more than GBMs and strike twice as many women as men, yet no standard chemo exists.
Scroll to Top
Separate tags by commas
To access this feature, please upgrade your account.